Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2005
12/28/2005EP0953642B1 Antigenic protein originating in infectious laryngotracheitis virus
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0742834B9 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
12/28/2005EP0682529B2 Antibody for the treatment of insulin dependent diabetes
12/28/2005EP0646175B1 Recombinant pseudomonas exotoxin with increased activity
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714148A Viral deconstruction through capsid assembly in vitro
12/28/2005CN1714100A Antigen peptides
12/28/2005CN1713921A Live attenuated vaccine against porcine pleuropneumonia
12/28/2005CN1713910A Azaindole derivatives as inhibitors of p38 kinase
12/28/2005CN1712068A Diploid-cell rabies vaccine and purified rabies vaccine, freeze-drying preparation and water injection thereof
12/28/2005CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
12/28/2005CN1233418C Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof
12/28/2005CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/27/2005US6979730 Nucleic acids encoding prostate stem cell antigen
12/27/2005US6979726 Immunoconjugates
12/27/2005US6979535 Diagnosing viral infection in mammals; obtain fluid sample, extract nucleotide sequences, incubate with viral probe, detect hybridization, hybridization signal indicates presence of viral sequence
12/27/2005US6979451 administering a vaccine to ruminants; antigen from tick cell culture, reducing infection in the ticks that feed on cattle
12/27/2005US6979450 A transdermal drug delivery device, e.g. patches, comprising topical application of an antigen and physiologically effective solution; in particular, using mycobaterial antigens to detect tuberculosis; efficient; sensitivity
12/27/2005US6979449 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
12/27/2005US6979448 Particles created by insertion of Mucin peptide epitopes into a plant virus (cowpea mosaic virus) with beta-barrel structure in its coat protein; good mucosal immunity with intranasal vaccine
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/27/2005CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
12/22/2005WO2005121378A2 Methods and compositions for vaccination
12/22/2005WO2005121343A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121338A1 Anti-perp antibody
12/22/2005WO2005121325A1 Heart and skeletal muscle inflammation (hsmi) virus
12/22/2005WO2005121179A2 Transferrin receptor antibodies
12/22/2005WO2005121177A2 Anti-il-13 antibodies, crystals of anti-il-13 antibodies and complexes comprising them
12/22/2005WO2005121175A2 Env polypeptide complexes and methods of use
12/22/2005WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci
12/22/2005WO2005121169A2 Apoptosis-inducing polypeptides
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005120638A1 Combination of radio waves and pharmacologically active substances
12/22/2005WO2005120583A2 Method for preventing or treating cardiac hypertrophy
12/22/2005WO2005120574A1 Drug having regulatory cell ligand contained in liposome
12/22/2005WO2005120571A2 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation
12/22/2005WO2005120570A2 Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis
12/22/2005WO2005120569A2 Improved therapeutic agent for inos generating illness
12/22/2005WO2005120568A1 Pharmaceutical composition comprising the anti-4-1bb antibody for treating or preventing rheumatoid arthritis
12/22/2005WO2005120567A2 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
12/22/2005WO2005120566A1 Dendrite cells transduced with recombinant adenovirus advcea which generate cea-specific cytotoxic t lymphocytes, vaccine and pharmaceutical composition comprising the same
12/22/2005WO2005120565A2 Sars vaccines and methods to produce highly potent antibodies
12/22/2005WO2005120564A2 Vaccine compositions and methods
12/22/2005WO2005120563A2 Induction of an immune response against streptococcus pneumoniae polysaccharides
12/22/2005WO2005120562A2 Structure-based receptor mimics targeted against bacterial superantigen toxins
12/22/2005WO2005120561A2 Vaccine against infection by a yersinia species
12/22/2005WO2005120560A1 Bacterial compositions for the treatment of cancer
12/22/2005WO2005120559A2 Charge gradient inhibition of trypanosoma cruzi and other parasite’s invasive action
12/22/2005WO2005120558A2 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
12/22/2005WO2005120552A1 METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION
12/22/2005WO2005120512A2 Cancer treatment method
12/22/2005WO2005120495A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
12/22/2005WO2005120437A2 Method for treating lupus
12/22/2005WO2005120231A1 Connective tissue growth factor regulates intracellular signaling pathways
12/22/2005WO2005110454A8 Protective binding members of pyy for the treatment of metabolic disorders
12/22/2005WO2005107767A3 Modulation of lysophosphatidylcholine and treatment of diet-induced conditions
12/22/2005WO2005097188A9 Method to decrease the risk of a vaccine-induced chronic immune mediated disorder in humans with a family history of the disorder
12/22/2005WO2005094533A3 Trail-r as a negative regulator of innate immune cell responses
12/22/2005WO2005094446A3 Anti-myostatin antibodies
12/22/2005WO2005081847A3 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
12/22/2005WO2005077003A3 Pili from mycobacterium tuberculosis
12/22/2005WO2005074645A3 Methods and compositions for modulating angiogenesis
12/22/2005WO2005070456A8 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
12/22/2005WO2005067477A3 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
12/22/2005WO2005060368A3 Humanized anti-ccr2 antibodies and methods of use
12/22/2005WO2005051321A3 Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase
12/22/2005WO2005051289A3 Homogeneous preparations of chimeric proteins
12/22/2005WO2005046621A3 Enhancement of vaccine-induced immune responses and protection by heterologous boosting with alphavirus replicon vaccines
12/22/2005WO2005037855A3 T cell epitopes useful in a yersinia pestis vaccine and as diagnostic tools and methods for identifying same
12/22/2005WO2005037235A3 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
12/22/2005WO2005013912A3 Anti-fcrn antibodies for treatment of auto/allo immune conditions
12/22/2005WO2004094613A3 Polyvalent protein complex
12/22/2005WO2004060317A3 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
12/22/2005WO2004058159A3 Branched immunomodulatory compounds and methods of using the same
12/22/2005WO2004027037A3 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
12/22/2005WO2004020610A3 Methods and compositions for modulating xbp-1 activity
12/22/2005WO2004002408A3 Cancer vaccine containing cross-species epitopes of telomerase reverse transcriptase
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283842 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282766 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/22/2005US20050282282 Methods of use of viral vectors to deliver antigen to dendritic cells
12/22/2005US20050282247 Recombinant single chain antibody in heterotrophic algae for pathogen control and use
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282210 Vaccination of skunks and/or mongooses against rabies
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050282163 Polymorphisms in elastin, fibrillin and related genes as predisposing to restenosis and to a therosclerosis
12/22/2005US20050281861 Macromolecule-containing sustained release intraocular implants and related methods
12/22/2005US20050281855 Process for preparing a cross-linked carboxyl polysaccharide and the cross-linked carboxyl polysaccharide
12/22/2005US20050281847 Vaccine composition
12/22/2005US20050281846 Local administration of a botulinum toxin, especially botulinum toxin type A, to an injured muscle to facilitate healing of injured biceps, knee or shin muscles.
12/22/2005US20050281845 Hapten-carrier conjugates and uses thereof
12/22/2005US20050281843 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
12/22/2005US20050281842 Inactivated bovine scours vaccines, process and method of preventing bovine scours
1 ... 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 ... 1823